Our finding, that higher levels of NSE in HD patients with poor outcome further strengthens the suggestion that NSE could be a potential marker for assessing the neurologic outcome, though it is important to stress that in acute events (e.g., stroke)47 NSE levels could differ from chronic situations like CKD. The gene discussed is ENO2; the disease is Stroke.